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ABSTRACT 
Identifying Protein-Protein Interactions 
of a Cell Cycle Regulator. (April 2001) 
Joseph Edward Amos 
Department of Biochemistry 
Texas A&M University 
Fellows Advisor: Dr. Sumana Datta 
Department of Biochemistry and Biophysics 
The role of anachronism (ana) protein in stem cell division of Drosophila 
melanogaster was examined. Synthesis of identifiable ana protein was necessary. The 
identifying method exploited was that of antibody tagging using a myc epitope or a poly- 
Histidine region. 
Analysis of previously utilized complementary DNA (cDNA) sequences showed 
errors in the alignment of the reading &arne. Methods were employed to clone the required 
ana cDNA sequence into an expression vector (pBAD/Myc-HisA) within the correct 
reading &arne. Restriction endonucleases were then used to confirm that the cDNA 
sequence and the expression vector had ligated properly. 
Analysis of the results &om the single- and double-restriction digests showed that 
the ana cDNA (1. 6 kilobases) was successfully cloned and ligated into the pBAD/Myc- 
HisA (4. 1 kilobases) expression vector. The ana cDNA was also successfully cloned in 
&arne with the sequence coding for the myc epitope and the poly-Histidine region. This 
data provides groundwork for the expression of identifiable ana protein. 
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INTRODUCTION 
Importance 
Cancer is caused by the uncontrollable division of diseased cells, while Alzheimer' s 
disease is caused by the loss of cells in certain areas of the brain. Although some of the 
mechanisms that cause these diseases are known, efficient treatments have yet to be 
discovered. By finding mechanism(s) that regulate cell division in Drosophila, we can 
develop ways to treat diseases in higher eukaryotes (i. e. , humans). Understanding these 
molecular mechanisms will have tremendous potential for drug design that could allow for 
the regeneration of damaged tissues, the treatment of neurological disorders, and the 
treatment of cancer. Directed control of cell division would allow treatments for diseases 
such as cancer and Alzheimer' s. 
Objective 
The broad purpose of this research is to further characterize the cell cycle in 
Drosophila melanogaster (fiuit fly). The specific goal of my project is to synthesize a 
protein that can be readily identified by a number of different techniques (Western blotting, 
immunohistochemistry, biochemical techniques). Also, this synthesis and identification 
must be easily reproducible. 
This thesis follows the style and format of Cell. 
Stem Cell Background 
Stem cells are of great interest to researchers because of their unique qualities: they 
can make a variety of tissues and they have the power of self-renewal. Upon division, they 
are able to renew or make almost all the tissues in the body (blood, brain, skin, germline, 
and other internal organs) and at the same time regenerate a second stem cell capable of the 
same function. Stem cells have an infinite capacity to renew our cellular count and their 
cell division is critical for fertility and replenishment of tissues and organs. The fact that a 
single transplanted stem cell can restore all of the blood cells in a mouse (Ikuta et al. , 1992) 
demonstrates this. Insufficient and/or uncontrolled stem cell division in humans can have 
detrimental effects, such as mental retardation (Miller, 1988), birth defects (Copp et al. , 
1988), and cancer (Ross et al. , 1995). In Drosophila, insufficient stem cell proliferation 
leads to behavioral defects, abnormal brain structure, and death (Datta and Kankel, 1992; 
Datta, 1995), while premature stem cell proliferation results in loss of olfactory sensitivity 
and unusual axonal patterning (Ebens et al. , 1993; Park et al. , 1997). This stem cell 
division has been shown to be controlled by the anachronism (ana) protein. 
Anachronism (ana) Protein Background 
Ana is a secreted glycoprotein expressed in glial cells of the central and peripheral 
nervous systems (Ebens et al. , 1993; Park et al. , 1997). The ana protein is required to 
maintain the mitotic quiescence of stem cells, but does not appear to regulate the identity or 
quantity of the stem cells (Ebens et al. , 1993). Interestingly, ana expression is not down 
regulated when the quiescent stem cells begin to divide (Ebens et al. , 1993), suggesting the 
existence of a mechanism(s) to inactivate ana or bypass ana-mediated repression. 
Analysis of the sequence (474 amino acids, 55kD) shows that ana is a novel protein: 
it shows no obvious homology to any other protein in the current database. Additionally, 
the current anti-ana antibody for identifying the protein is unsatisfactory and does not work 
well in biochemical techniques. As a result, we need to develop a way to make a currently 
existing antibody recognize ana. To do this, we are employing a system called epitope 
tagging. 
An epitope is that part of the structure that reacts with a specific antibody. Epitope 
tagging is simply adding an epitope to the structure of interest (protein, carbohydrate, etc. ). 
For optimal results, we want to use an antibody that is reliable, commercially available, has 
been shown to work in biochemical techniques, and is unique to Drosophila. The epitope 
that we are tagging ana with is a myc epitope (part of the myc oncoprotein). The myc 
epitope has readily available antibodies that have been shown to work in Western blot 
analysis, immunoprecipitation, and immunohistochemistry. Furthermore, the coding 
sequence for the myc epitope is widely accessible and the myc epitope does not occur 
naturally in Drosophila. 
OBJECTIVES 
I. To synthesize ana-myc protein 
~ Protein must be functional, identifiable, able to be secreted 
II. Determine protein-protein interactions of ana 
~ What does ana interact with 
~ Find and characterize what proteins interact with ana 
III. Understand how the protein-protein of ana interactions influence the regulation of 
stem cell division 
MATERIALS AND METHODS 
Sources of DNA 
The ana cDNA used in the experiments was readily available in the laboratory as a 
result of other's work (Colleen Hough). The ana cDNA was contained in a carrier vector 
termed pUC and was given the designation pUC ana SB 39 (Figure I). This vector has two 
restriction sites, Eco Rl and Hind III, surrounded the ana cDNA. 
The other vector used, pBAD/Myc-His A, was commercially available through 
Invitrogen™ Corporation (Invitrogen~ ¹V440-01). This vector has the coding region for 
both the Myc epitope and for a poly-Histidine region (Figure 2), as well as restriction sites 
for Eco Rl and Hind III (Figure 3). This allows two methods of identification: myc 
antibodies and poly-Histidine antibodies. These antibodies can also be used for purification 
techniques. 
Reticulocyte Lysate System 
The primary and simplest strategy for making a tagged ana protein is to use a 
coupled transcription/translation system The system we used was the Promega TNTR 
Coupled Reticulocye Lysate System (Promega ¹L4610). This system used a T7 RNA 
polymerase promoter and radiolabeled (via S) our protein using only the protein's cDNA 
and the cellular components of rabbit blood. The advantages of this system are that it 
simplifies the process (transcription/translation are coupled), produces more protein than 
standard reticulocyte systems, and incorporates significantly more "S than standard 
translation reactions. We also used an additional DNA (Leo DNA) as a positive control for 
our reticulocyte system. Leo is a protein that is naturally in Drosophila, and is only used as 
a control. 
Transformation 
The vectors used were first transformed into E. col/ cells. Once transformed, the 
cells were allowed to grow and multiply on media plates that contained ampicillin, which 
allowed us to screen for vectors that had ampicillin resistance (pUC ana SB 39 and 
pBAD/Myc-His A). Once grown, the DNA was then recovered &om the E. col/ cells using a 
plasmid mini-prep and phenol chloroform cleanup. This straightforward procedure allowed 
us to produce an extremely large quantity of our DNA's, which were then used in 
subsequent experiments. The DNA was stored at -20'C until use. 
Restriction Digests 
The DNA recovered &om the E. co/i transformations was treated with restriction 
endonucleases Eco Rl and Hind III. The restriction &agments &om these digests were then 
run on a 0. 6'lo LM agarose electrophoresis gel to check the size of the DNA and verify that 
we were working with the correct copies. The DNA &agments were gel purified using 
QIAquick Gel Extraction Kit (QIAGEN //28706) and stored at -20'C until use. 
Hin d III (3825) 
ana CDNA 
pUC ana SB 39 
4227 bp 
Eco R I (2233) 
Figure i. Camer vector containing ana cDNA 
EcoR I Hind III myc epitope 
I I 
357 GGAATTCGAA GCTTGGGCCC GAA CAA AAA CTC ATC TCA GAA GAG 
Glu Gln Lys Leu Ile Ser CTlu Glu 
Polyhistidine Region 
GAT CTG AAT AGC GCC GTC GAC CAT CAT CAT CAT CAT CAT TGA 
Asp Leu Asn Ser Ala Val Asp His His His His His His 
Figure 2. Coding region for Myc epitope and for poly-Histidine region 
(taken Irom Invitrogen™ Instruction Manual) 
Eco R! (360) 
Hin d III (367) 
pBAD/Myc-His A 
4096 bp 
Figure 3. Invitrogen™ pBAD/Myc-His A vector 
Cloning DNA 
Once both the ana cDNA &agment and pBAD/Myc-His A fragment were purified, 
they were ligated together. This ligation produced a new vector pBAD Mye-His/ana cDNA 
(Figure 4). This new vector used pBAD as the earner and had cloned in to it the ana 
cDNA. The ana cDNA was meticulously placed in &ont of the coding region for the Myc 
10 
epitope and for the poly-Histidine region. Double restriction digests (Eco Rl and Hind HI) 
were used to confirm the presence of the DNA fi'agments (ana cDNA and pBAD). 
Eco R I (360) 
pBAD Myc-HisA/ana cDNA 
5681 bp 
ana cDNA 
Hin d III (1952) 
Figure 4. pBAD Myc-His/ana cDNA vector 
Protein Expression 8r Visualization 
The protein expression vector was expressed using E. coll TOP 10 according to the 
Invitrogen™ protocol. The samples (before and after induction) were analyzed on an SDS- 
PAGE gel and stained with Coomassie blue. The samples used were: 1) Kaleidoscope 
Marker, 2, 3) pBAD/Myc-His/lacZ (before/aller induction, positive control), 4) pBAD Myc- 
His/ana cDNA (before induction), 5) pBAD Myc-His/ana cDNA (after induction, 0. 0002'/0 
L-arabinose), 6) pBAD Myc-His/ana cDNA (aller induction, 0. 002'/0 L-arabinose), 7) 
pBAD Myc-His/ana cDNA (aller induction, 0. 02'/0 L-arabinose), 8) pBAD Myc-His/ana 
cDNA (atter induction, 0. 2'/0 L-arabinose), 9, 10) pBAD/Myc-His A (before/after 
induction). 
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RESULTS 
Our preliminary experiments involved protein production via the Reticulocyte 
Lysate System and antibody tagging through Western Blotting. It is crucial for us to be 
able to easily mark and identify our ana-myc protein for further experimentation. First, 
experiments were run to ensure that our reticulocyte system was transcribing and translating 
our cDNA and that it was utiTizing the methionine radioactively labeled with sulfur ("S). 
The cDNA used in the experiments is pBS11 SK ana myc and was constructed by Colleen 
Hough. In this vector it is assumed that the cDNA of ana and the coding sequence of the 
myc epitope are correct and in kame. The results (Figure 5) show that our cDNA construct 
is able to undergo eukaryotic in vitro translation via the reticulocyte system The S was 
actively used in the transhtion of the nascent proteins. When this film was compared to the 
marker, the size of the bands in each lane closely corresponds to the estimated size of ana- 
myc protein (-57kD). 
Next, the reticulocyte experiment was run with Leo DNA (as a positive control), 
ana cDNA (ana RX-7 ¹3, as a negative control), and ana-myc cDNA (pBS11 SK ana 
myc). These proteins were then transferred to a nitrocellulose membrane and treated with 
myc antibodies as well as a chemiluminescence solution. Leo protein can be used as a 
positive control because we have specific antibodies that have been shown to react with 
only Leo and our ana protein can be used as a negative control because it should have no 
@unity for the myc antibody. These results (Figure 6) were very poor. Our myc antibodies 
showed alfinity for everything (proteins and miscellaneous things) on the membrane, 
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including the "No DNA" control lane. This shows that the myc-antibodies have affinity for 
something found in the Reticulocyte Lysate System To double check that in vitro 
translation was working, we stripped the membrane and treated it with Leo antibody. 
Figure 7 shows the Leo antibody having affinity for the Leo protein, while not cross- 
reacting with other proteins present. This demonstrates that the Reticulocyte Lysate System 
is functioning appropriately. From these results, we concluded that the myc antibodies 
themselves could have been bad, and decided to order new ones (Santa Cruz ¹sc-2004). 
ac) g 
-43kD 
Figure 5. Exposure of 'S in nascent in vitro translation 
Figure 6. Western blot of Leo DNA, ana RX-7¹3, and pBS11SKana-myc 
probed with anti-myc antibody 
15 
Figure 7. Antibody tagging using Leo antibody 
We then proceeded to once again run Leo DNA, ana RX-7 ¹3, and pBS I I SK ana 
myc in the Reticulocyte Lysate System After we transferred this to a nitrocellulose 
membrane, we treated with our new myc antibodies. This experiment produced exciting 
results (Figure 8). The lane in which we expected to find our ana-myc protein stained with 
the new myc antibody, and rough molecular weight ca)culations were close to expected 
values (57Kd expected vs. 59Kd calculated). However, these results proved to be 
irreproducible. Several subsequent Lysate System/Western blotting experiments showed no 
reaction to the myc antibody, suggesting no ana-myc protein being made (Figures 9 and 
10). However, Figure 10 does show weak bands across. In order to determine what these 
bands could be, we used an antibody that recognizes Histidine repeats. We expected to see 
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the Histidine antibody react with ana and ana-myc proteins because ana has a 6-Histidine 
repeat at the c-terminal end. For this experiment, we stripped the membrane used in Figure 
10 and treated with the Histidine antibody. Figure 11 shows that nothing on the membrane 
(also used for Figure 10) had atfinity for the Histidine antibody. As a positive control, we 
ran a new gel using protein extracted )rom 1, 2, and 3 instar CS larvae (50 f'rom each 
stage, 15uL samples) and ana protein samples previously made &om the Reticulocyte 
Lysate System that we suspected had the protein. We know that ana protein is expressed in 
larvae stages and therefore should be present in the larvae samples. Figure 12 shows the 
two Reticulocyte Lysate samples of ana protein reacting with the Histidine antibody. 
However, the molecular weight determinations showed these bands to be around 40kD, 
illustrating the two samples could not have contained ana protein (-55kD). This shows that 
the weak bands in Figure 10 are not due to the presence of ana or ana-myc protein. 
Additionally, the Histidine antibody did not react with larvae extracts showing that either 
antibody (myc or Histidine) could be used in identification experiments. 
CJ 
Iii ik» 
7kD 
ana-myc 
protein? 
Figure 8. Positive results of Western Blot of ana-myc 
pV 
g o p J o 
~ ~ I ~ 
~ j 
Figures 9. Primary negative results of Western blot of ana-myc 
Figure 10. Secondary negative results of Western blot of ana-myc 
Figure 11. Old membrane treated with Histidine antibody 
atta sample 
lh2 
Figure 12. New membrane treated with Histidine antibody 
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The next system we utilized was a prokaryotic expression system called 
pBAD/Myc-His. The results &om the double restriction digests, using enzymes Eco RI and 
Hind III, are presented below. The pUC ana SB 39 and pBAD/Myc-His A digestion 
products are shown in Figure 13. This picture shows the two DNA Iragments: ana cDNA 
&agment (1. 6 Kb) and pBAD/Myc-His A fiagment (-4 Kb). This experiment confirmed 
that we excised the correct pieces of DNA and were then ready to ligate (Figure 14) the two 
to produce a new vector. The new vector will be one in which the ana cDNA would be in 
font of and in kame with the myc epitope/polyhistidine region on the pBAD vector. 
~ ~ 
g' ~ ' 
Figure 13. Double Digest of pUC ana SB 39 and pBAD/Myc-His A 
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IIIyc 
6x His 
pBAD/Myc-His 
A, B. C 
4 I x6 
dna cg 
EccR I 
v 
poc xcx 
SB 39 
4. 3 I 9Kb 
Restriction 
Endonucleases 
EcoRl & 
Hindlll 
Ligation 
ana cg 
Ecos I 
icdlll 
txa cby 
lilpc 
6x Hix 
pBAD/Myc-His 
A, B, C 
4. 1 kb 
Figure14. Ligation of ansi cDNA &agment and pBAD/Myc-His A &agment 
Once the ligation of the two DNA pieces was complete, confirmation of the two 
&agments was done using enzymes Eco RI and Hind III. The results of that double digest 
are shown in Figure 15. These results show that we have ligated the correct pieces of DNA 
together, and are now ready to induce production ofana-myc-his protein. 
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~ I 
sL' 
~ 
~ ~ 
Figure 15. Double Digest of pBAD Myc-His/ana cDNA 
Preliminary expression results using SDS-PAGE analysis and Coomassie blue 
staining show three possible ana-myc proteins (Figure 16). The positive control, lacZ, 
showed a stronger band atter induction, signifying that the expression is working. 
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Tac'Z 
:. indlcjon 
pBAT) Qyc-His/ana cd%~ p~ 
Myc-His A 
h T 
~t 
Figure 16. Preliminary expression results 
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CONCLUSIONS 
General Considerations 
Several key elements must be considered and maintained in order to synthesize a 
tagged protein. First, the correct cDNA sequence must be obtained for both the protein and 
the tag. Next, the two cDNA's must be joined in kame, so that the translation of the entire 
sequence results in the protein and tag being synthesized. Then, the question of whether the 
protein is fully functional arises. And if the protein is made and is functional, then the 
process must be reproducible. 
Reticulocyte Lysate System 
The Reticulocyte Lysate System would have been the most straightforward and 
simplest approach to making our labeled protein. However, the positive results (Figure 8) 
were unable to be confirmed. It turned out that the irreproducible results were for good 
reasons. Upon close analysis, the construct of ana cDNA and myc-epitope sequence 
(pBS11 SK ana myc) was not properly created. The source of myc epitope sequence used 
in this construct is uncertain. Also, the PCR technique used to change the stop codon may 
not have yielded the insert expected. As the consequence of Colleen Hough's research, the 
correct myc epitope sequence was not added in kame with the ana cDNA, thus making it 
impossible to synthesize an ana protein with a myc epitope. 
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pBAD/Myc-His System 
The results of the double digest of pUC ana SB 39 and pBAD/Myc-His A (Figure 
14) show that the correct ffagments have been excised. We have then taken the ana cDNA 
ffagment and cloned it into the pBAD/Myc-His vector. Analysis of the double digest of 
pBAD Myc-His/ana cDNA (Figure 15) shows that we have successfully ligated the correct 
two pieces of DNA together. This new vector contains the correct myc epitope sequence 
and is in frame with the ana protein. Preliminary expression results using SDS-PAGE 
analysis and Coomassie blue staining show three possible ana-myc proteins (Figure 16). 
Future Research 
Now that we have the proper construct of ana cDNA and myc-epitope sequence 
(correct sequence and in fame), we can transform this vector back in to E. col/. Once 
transformed, we will induce E. col/ to transcribe and translate our protein using its own 
cellular machinery. The bacteria will transcribe and translate &om the beginning of the ana 
cDNA sequence through the myc-epitope and poly-Histidine sequences, producing an ana- 
myc-polyHis protein. 'fhis protein should react with myc antibodies as well as poly- 
Histidine antibodies. Once this protein is made and easily identiffed, we will verify that it 
is fully functional. 
This project set out to ffnd the protein-protein interactions of ana. To do that, we 
had to devise a method for synthesizing a readily identifiable protein. That method proved 
to be somewhat more difficult than expected. At the moment we are not able to answer the 
questions set forth, but our results show we have made great progress in the direction of 
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those answers. Currently, Western blot analysis is underway to confirm that ana is in kame 
with the myc epitope using the pBAD system. With continued research of this project, we 
will soon be able identify ana's interactions. 
27 
REFERENCES 
Becker, T. and Technau, G. (1990). Single cell transplantation reveals interspecific cell 
communication in Drosophila chimeras. Development 109, 821-832. 
Copp, A. J. , Brook, F. A. and Roberts, H. J. (1988). A cell-type-specific abnormality of cell 
proliferation in mutant (curly tailed) mouse embryos developing spinal neural tube 
defects. Development 104, 285-295. 
Datta, S. (1995). Control of proliferation activation in quiescent neuroblasts of the 
Drosophila central nervous systetn. Development 121, 1173-1182. 
Datta, S. and Kankel, D. R. (1992). i(1)irol and 1(1)devi, loci affecting the development of 
the adult central nervous system in Drosophila meianogasrer. Genetics 130, 523- 
537. 
Ebens, A. J. , Garren, H. , Cheyette, B. N. R. and Zipursky, S. L. (1993). The Drosophiia 
anachronism locus: A glycoprotein secreted by glia inhibits neuroblast proliferation. 
Cell 74, 15-28. 
Ikuta, K. , Uchida, N. , Friedman, J. and Weissman, I. L. (1992). Lymphocyte development 
&om stem cells. Annual review of Immunology 10, 759-783. 
Miller, R. W. (1988). Intrauterine radiation exposures and mental retardation. Health 
Physics 55, 295-298. 
Park, Y. , Caldwell, M. C, and Datta, S. (1997). Mutation of the central nervous system 
neuroblast proliferation repression ana leads to defects in larval olfactory behavior. 
J. Neurobiology 
28 
Ross, R. , Spengler, B. , Domenech, C. , Porubcin, M. , Rettig, W. and Biedler, 3. (1995). 
Human neuroblastoma I-type cells are malignant neural crest stem cells. Cell 
Growth & Di(K 6, 449-456. 
Truman, 3. W. and Bate, M. (1988). Spatial and temporal patterns of neurogenesis in the 
central nervous system of Drosophila melanogasrer. Dev. Biol. 125, 145-157. 
29 
Vita 
Name: Joseph Edward Amos 
Permanent Address: 114 Stephanie Dr. 
Palestine, TX 75801 
Educational Background: Texas A & M University 
Bachelor of Science Biochemistry, May 2001 
Fall 1998-Spring 2001 
Kilgore College 
Summer 1997-Fall 1998 
Honors: Phi Theta Kappa International Honor Society (1997); Golden Key National Honor 
Society (1999); Nominated for Pfizer Undergraduate Fellowship (2000); Texas 
A&M University Undergraduate Research Fellow (2000-01); Biochemistry 
Research Scholar (2000-01); Cherokee County Aggie Moms Scholarship (2000); 
TAMU Summer University Undergraduate Research Fellow (2000); Howard 
Hughes Honors Scholarship (2000); Julia Ball Lee Memorial Scholarship (2000); 
Houston Rodeo Endowed Scholarship (2000); Texas A& M Club of Albuquerque 
Scholarship (2000); Dean's Honor Roll (2000); Phi Kappa Pbi Honor Society 
(2001); Nominated for Senior Merit Award (2001) 
Research Experience: Texas A&M University Biochemistry/Biophysics Laboratory, Texas 
A&M University Undergraduate Research Fellows Program, Biochemistry Research 
Scholars Program 
